You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 18, 2023

Thailand Approves New Private Placement Rules for Listed Companies

Thailand’s Office of the Securities and Exchange Commission (the “SEC Office”) has revamped various rules relating to private placements by listed companies with a view to streamlining the offering process and reducing the documentation required for submission to the SEC Office. Most of these rules were revised by the Capital Market Supervisory Board on December 28, 2022, and will come into effect on July 1, 2023.

The key amendments in the new rules are summarized below.

Elimination of Application Requirement

Issuers are no longer required to apply to the SEC Office prior to offering their shares via private placement, according to new rules laid out in the Notification of the Capital Market Supervisory Board No. TorChor 28/2565 Re: Permission for Listed Companies to Offer Newly Issued Ordinary Shares via Private Placement (the “TorChor 28/2565 Notification”). The rules detailed in this notification will replace the current private placement rules under the Notification of the Capital Market Supervisory Board No. TorChor 72/2558 Re: Permission for Listed Companies to Offer Newly Issued Ordinary Shares via Private Placement.

Under the TorChor 28/2565 Notification, issuers may offer their shares via private placements that are share offerings to no more than 50 high-net-worth or ultra-high-net-worth investors within 12 months, share offerings valued at no more than THB 20 million within 12 months, or share offerings to institutional investors (excluding share offerings to the issuer’s directors or employees), so long as the issuer complies with its information disclosure and corporate approval requirements, which remain mostly unchanged under the new notification.

To fulfill these requirements, notice of a shareholders’ meeting must be submitted to all shareholders at least 14 days in advance, and the offering must be approved by a supermajority vote of the shareholders, which means approval by at least three-fourths of the shareholders present and entitled to vote at the shareholders’ meeting. If the offering price is lower than the market price, there must be no veto of the offering by shareholders holding 10 percent or more of the total issued shares in aggregate (but see additional requirements described in the next section).

Thanks to this no-filing approach, the issuer can now place remaining shares from a rights offering (RO) or a preferential public offering (PPO) via private placement with more flexibility, provided that the issuer complies with the 14-day notice requirement, obtains a supermajority vote from the shareholders’ meeting, and receives a clear mandate from the shareholders’ meeting to place the shares at a price that is not lower than the offering price of the RO or PPO.

Submission of Independent Financial Advisory Opinion

Despite adopting this deemed-approval approach and eliminating the filing requirements, the Capital Market Supervisory Board has introduced a new requirement under the TorChor 28/2565 Notification requiring issuers to submit the opinion of an independent financial advisor (IFA) together with the notice of the shareholders’ meeting. This requirement, which does not apply to private placements of any remaining shares from an RO or PPO, is triggered for “material” offerings in any of the following cases:

  • The offering price is lower than the market price;
  • The offering of shares may result in any investor being a shareholder with the highest voting rights in a listed company—including shareholding by any person under Section 258 of the Securities and Exchange Act B.E. 2535, as amended (e.g., the investor’s spouse and minor children, any juristic person in which the investor together with his or her spouse and minor children has more than 30 percent shareholding, or any person having more than 30 percent shareholding in the investor as a juristic person); any concert party of the investor; and any person under Section 258 of the concert party of the investor; or
  • The offering of shares may affect the earnings per share dilution or control dilution of at least 25 percent of the number of paid-up shares before the date on which the board of directors resolved to propose the offering to the shareholders’ meeting.

The opinion of the IFA must contain at least the following information:

  • Appropriateness of the offering price and conditions of the offering;
  • Reasonableness and benefits of the offering to the investors, including the use of proceeds, in comparison with the impacts on the shareholders; and
  • An opinion (with reasons) on whether the shareholders should vote to approve the offering.

The issuer must submit the draft notice of the shareholders’ meeting and the draft opinion of the IFA to the SEC Office via the office’s e-submission system. The SEC Office will provide feedback within five business days of all documentation being submitted.

Simplification of Market Price Calculation

The TorChor 28/2565 Notification now provides that the issuer must first use the weighted average price of the shares as a benchmark to determine the market price, except when the weighted average price cannot be calculated or is not suitable due to the liquidity of the issuer’s shares. In such a case, the issuer must use the book-building price first, or the fair price determined by a qualified financial advisor if there is a reason the book-building price cannot be used.

In this regard, “weighted average price” means the weighted average price of the issuer’s shares traded on the Stock Exchange of Thailand over at least seven (but no more than 15) consecutive business days before the offering date. The offering date is figured as either the date on which the board of directors determined the offering price (if the board of directors received a mandate from the shareholders’ meeting to determine the offering price based on the market price), or the date on which the board of directors proposed the offering at a specific price to the shareholders’ meeting for approval.

Moreover, the board of directors may set the offering price higher than the calculated weighted average price or at a discount of up to 10 percent by taking into account the market conditions if there are reasonable grounds for doing so and the board of directors has considered the company’s best interests.

Clarification of Offering Period

The TorChor 28/2565 Notification also clarifies the offering period for each placement type. If a shareholders’ meeting grants the board of directors a mandate to determine the offering price based on the market price, the TorChor 28/2565 Notification requires that each placement be completed within five business days after each determination of the offering price by the board of directors, and the offering period cannot exceed 12 months from the shareholders’ meeting.

If the shareholders’ meeting approves a private placement at a specific price, the placement must be completed within three months from the shareholders’ meeting. After these three months, the board of directors may be authorized by the shareholders’ meeting to further determine the offering price based on the market price, in which case the offering period can be extended to a maximum of 12 months from the shareholders’ meeting, but each placement must still be completed within five business days after each determination of the offering price by the board of directors.

As for the placement of remaining shares from an RO or PPO, this must be completed within three months after the end of the subscription period of the RO or PPO.

For more details on these latest rules for private placements by listed companies, or on any aspect of complying with securities laws and regulations in Thailand, please contact Tilleke & Gibbins at [email protected] or [email protected].

RELATED INSIGHTS​ 

March 29, 2023
On March 14, 2023, the Competition Commission of Cambodia (CCC) set out its merger filing thresholds in Decision No. 095 on Thresholds for Prior Notification of Business Mergers. This was a follow-up to the recent issuance of a regulation outlining the requirements and procedures for merger and acquisition filings. Decision No. 095 applies to all business combinations subject to premerger notification requirements under this prior regulation. The thresholds for when the CCC must be notified of a merger are laid out in the table below. In current practice, the term “turnover” typically refers to a company’s total sales revenue, while “input purchase turnover” denotes the value of materials or equipment acquired for production purposes. Although this reflects the initial interpretation of these terms, it is advisable to seek confirmation or clarification from the CCC before the filing to ensure accuracy and alignment with their current definitions, as it is conceivable that the interpretation may change. Decision No. 095 leaves room for the Ministry of Commerce to amend these thresholds as deemed necessary. Outlook In the last two years, Cambodia has steadily issued regulations to strengthen its legal framework for competition. Although gaps remain, especially with regard to enforcement of fines and certain unclear terms, more regulations are likely in 2025 and 2026.
March 22, 2023
Attorneys from Tilleke & Gibbins have contributed the Cambodia, Laos, Myanmar, and Vietnam sections to DLA Piper’s Global Government Contracting Country by Country guide, which provides essential information for businesses in 75 jurisdictions on how to source and enter into government contracting opportunities. The guide provides procurement information for jurisdictions in Africa, the Americas, Asia-Pacific, Europe, and the Middle East, and includes information on how to find procurement opportunities, the structure of procurement laws, and in-country resources and relevant publications. Each jurisdictional section includes valuable information on procedures for government tenders, bidding, and contract execution, as well as an overview of the legal and regulatory framework governing government procurement. Businesses can refer to the guide to gain a better understanding of procurement processes and regulations in each jurisdiction, which can help them identify potential opportunities and make informed decisions when pursuing government contracts. The guide’s procurement information for Cambodia, Laos, Myanmar, and Vietnam, combined with the online platform’s comprehensive resources, provides businesses and governments with a valuable tool to navigate the complex regulatory landscape of government contracting in the region. The full Global Contracting Country-by-Country guide is available on the DLA Piper website.
March 17, 2023
On March 6, 2023, Cambodia issued requirements and procedures for merger and acquisition (M&A) filings to allow the country’s competition regulator to monitor the impact of M&A transactions on the Cambodian market. These rules are contained in Sub-decree No. 60 on the Requirements and Procedures for Business Combinations. This subdecree is the latest in a series of detailed regulations issued to develop Cambodia’s competition and antitrust law framework since the 2021 enactment of the Law on Competition, which formally established the Cambodia Competition Commission (CCC), set out the CCC’s complaint and investigation procedures, listed prohibited anticompetitive practices, and outlined applicable penalties. Sub-decree No. 60 applies to any business combination that may materially affect competition in Cambodia, regardless of where in the world it takes place. Premerger and Postmerger Notifications The parties to a business combination must notify the CCC of the proposed combination if the transaction meets certain thresholds, which will be determined by the CCC at a future date. The notification must include, among other things, key terms of the relevant agreements, incorporation documents and financial statements of the parties, and an indication of the types of goods or services provided by the parties. All documentation submitted must be in Khmer, except for names, addresses, and certain other items. The CCC will determine within seven working days whether it requires additional information or documentation. Once it has all necessary documentation, the CCC will issue a decision on the proposed business combination within 30 days—the combination may be approved outright or declared subject to a secondary review. Sub-decree No. 60 states that a proposed business combination will not be subject to secondary review if the market share of each party does not exceed 30 percent in each relevant market, among other criteria. However, the CCC reserves to right to
March 7, 2023
According to the Ministry of Health of Vietnam, many healthcare facilities in the country are facing a shortage of drugs, medical devices, and materials/chemicals. To address the urgent needs of medical examination and treatment in public healthcare facilities, on March 4, 2023, the government of Vietnam promulgated Resolution No. 30/NQ-CP on continuing to implement solutions to ensure the availability of drugs, medical equipment, and healthcare supplies (“Resolution 30”). Resolution 30 amends item 4 of Resolution No. 144/NQ-CP dated November 5, 2022, allowing medical examination and treatment expenses to continue to be covered by health insurance for technical services carried out with medical devices supplied by contractors after winning tenders to supply materials and chemicals. The new mechanism brings more benefit to patients by removing the previous ending date of November 5, 2023, and will be applicable until there is further guidance from the government. Resolution 30 also allows the use of medical devices that were donated or gifted by domestic and foreign entities (including those that were provided under now-expired joint ventures or cooperation contracts) regardless of whether those entities have fulfilled the procedures for ownership establishment. Technical services that are performed by such devices will be covered by health insurance. This provision will help address the shortage of medical devices used in public hospitals. The determination of bid price is also a highlight of Resolution 30, which pilots a simpler price determination procedure for the purchase of drugs and medical devices. Instead of requiring purchasers to obtain quotations from three suppliers, Resolution 30 allows them to compare prices based on the quotations actually received, even from only one or two suppliers. Alternatively, price determination can be based on the winning bid price for a similar medical device procurement package that was awarded within the last 120 days. This